LCN2 and metabolic dysfunction-associated steatotic liver disease: An overall increase in circulating LCN2 is observed in NAFLD patients, as compared to healthy controls, which additionally correlated to insulin resistance and inflammation (this latter was evaluated through CRP) (89).